Cochrane COVID-19 Studienregister
Studienbericht
NCT05074017Erstmals veröffentlicht: 2021 Okt 12Letzte Aktualisierung: 2021 Okt 12

COVAG Study - Covid-19 Antigen Study

  1. Studientyp
  2. Observational
  1. Studienziel
  2. Diagnostic/Prognostic
  1. Studiendesign
  2. Other
  1. Interventionszuordnung
  2. Not Applicable
Referenzdatensätze

COVAG - Covid-19 Antigen Study

Synlab Holding Deutschland GmbH
Erstmals veröffentlicht (first received 2021 October 12)ClinicalTrials.gov (https://clinicaltrials.gov/show/NCT05074017)
Eintrag in Studienregister
Keine Ergebnisse
The aim of the COVAG study (Covid-19 Antigen study) is to assess the diagnostic efficacy of two of the most used rapid antigen tests (Roche & Abbott). The study will be performed at the Corona Test Center Stuttgart Cannstatter Wasen. Approximately 2000 patients will be enrolled after having signed the Informed Consent Form (ICF). Each patient will receive 3 nasopharyngeal swabs. Two for the rapid antigen tests from Roche and Abbott and one for the RT-PCR. Furthermore an anamnesis, short clinical examination and blood draw is done. The blood is examined for SARS-CoV-2 antibodies and basic laboratory tests to be communicated to participants